ANDA 202601, held by Zydus Pharms. Clonidine Hydrochloride.
As of Nov 16, 2026, ANDA 202601 (Clonidine Hydrochloride), held by Zydus Pharms, was first approved by FDA on Feb 20, 2014, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 20, 2014 | Original application | Approved | None posted |
| Clonidine Hydrochloride1MG/10ML (0.1MG/ML) · injectable;injection | Clonidine Hydrochloride | Rx |
| Clonidine Hydrochloride5MG/10ML (0.5MG/ML) · injectable;injection | Clonidine Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters